| Name | 5-bromo-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
|---|---|
| Synonyms |
1-(β-D-abino-furanosyl)-5-broMouracil
1-beta-D-abinofuranosyl-5-bromouracil 5-BroMoarabinouridine 2,4(1H,3H)-Pyrimidinedione, 1-β-D-abinofuranosyl-5-bromo 2,4 (1H, 3H)-Pyrimidinedione, 1-.beta.-D-abinofuranosyl-5-bromo 5-Bromoabinouridine, 1-(β-D-abino-furanosyl)-5-bromouracil 5-BroMoabinouridine |
| Description | 1-β-D-Arabinofuranosyl-5-bromo-2,4(1H,3H)-pyrimidinedione is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 2.043g/cm3 |
|---|---|
| Molecular Formula | C9H11BrN2O6 |
| Molecular Weight | 323.10 |
| Exact Mass | 321.98000 |
| PSA | 124.78000 |